Interestingly, none of the DNMT3A R882 mutant cases with coexisting SF3B1 or SRSF2 mutations had AML transformation (33% vs. 0%, p=.03 by Fisher’s exact test when combining both). The gene discussed is DNMT3A; the disease is acute myeloid leukemia.